NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
A high-stakes mission was undertaken at Concord Hospital this week — an exercise to test how multiple government agencies ...
Democratic Republic of Congo announced the end of an almost six-month Ebola outbreak in the west of the country on Wednesday as health authorities looked to apply lessons from the successful response ...
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
Yesterday the World Health Organization (WHO) confirmed that last patient being treated for Ebola virus disease in an ...
The World Health Organisation said 57 cases and 35 deaths have been reported since the outbreak was announced by Congolese authorities on September 4, with a fatality rate of over 61 per cent. It is ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the ...
Models were more consistent than individual experts but performed comparably to ensembles of many experts and relative performance varied by month, justifying the use of combined model and expert ...
Featured In Analyst Report Highlighting Dual-Track Clinical Strategy For NV-387. NanoViricides, Inc. (NYSE American: NNVC) announced that Proactive Investors published an analyst research report ...
Let's face it—bats get a bad rap. Their links to disease outbreaks and their spooky association with vampires influence their ...
Efforts like NASA's Planetary Defense Coordination Office aim to detect and deflect potential threats. This isn't just ...